Hormone Therapy News

Menopausal hormone therapy does not affect risks for cardiovascular disease or type 2 diabetes, according to findings from a study of middle-aged postmenopausal women in South Korea published in Menopause.

The offspring of mothers who received 17-hydroxyprogesterone caproate during pregnancy may face nearly double the risk for cancer compared with those who were not exposed, according to a recent study.

The relugolix combination therapy known as Myfembree provided long-term benefits in women with uterine fibroids and significantly improved daily functioning in women with endometriosis, data from two studies showed.

Estrogen dosage, the type of formulation and the number of years since menopause may alter a woman’s risk for hypertension, according to data from the Women’s Health Initiative Observational Study published in Menopause.

Women with migraine headaches should receive targeted atherosclerotic cardiovascular disease prevention, including attention to safer contraception and safe menopausal hormone therapy, beginning in young adulthood, according to a speaker.

The FDA approved the first once-weekly formulation of somatropin for children with growth hormone deficiency, according to an industry press release.

Risk for venous thromboembolism does not differ for women using oral conjugated equine estrogen vs. oral or transdermal estradiol, according to a study published in Menopause.

Testosterone therapy was not associated with unexpected or rapid disease progression in a cohort of men with biochemical recurrence or metastatic prostate cancer, according to study findings. 

A longer duration of extended hormone therapy provided no benefit for postmenopausal women with hormone receptor-positive breast cancer who had received 5 years of adjuvant endocrine therapy, according to randomized phase 3 study results.

Collaboration, understanding a youth’s goals and detailing a transition plan are three ways providers can help transgender adolescents shift from pediatric to adult care, according to findings published in LGBT Health.